SCHEMBL3036532

SCHEMBL3036532

CC(C)(C)OC(=O)C(C(=O)OC(C)(C)C)c1ccc([N+](=O)[O-])c(Oc2ccccc2)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.35
POLB P06746 2/20 0.35
HTT P42858 1/20 0.35
PKM P14618 1/20 0.35
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
TTR P02766 1/20 0.34
ALB P02768 1/20 0.34
THRB P10828 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NPSR1 Q6W5P4 3/20 0.34
ATM Q13315 1/20 0.34
ITGA4 P13612 1/20 0.34
ITGB7 P26010 1/20 0.34
LMNA P02545 2/20 0.33
BCL2 P10415 1/20 0.33
XDH P47989 1/20 0.33
HPSE Q9Y251 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2434984 0.84 ALDH1A1 (0.39) ALDH1A1POLBHTTKMT2AMEN1
SCHEMBL3023941 0.83 PIN1 (0.41) ALDH1A1MAPTHTTPKMKMT2A
SCHEMBL3640569 0.81 ALDH1A1 (0.33) ALDH1A1MAPTPOLBHTTKMT2A
SCHEMBL3031361 0.80 CYP3A4 (0.38) MAPTKMT2ALMNA
SCHEMBL13983329 0.78 MAPT (0.33) ALDH1A1MAPTHTTPKMKMT2A
SCHEMBL13982852 0.76 CYP3A4 (0.38) MAPTPKMKMT2AMEN1THRB
SCHEMBL3414946 0.75 ALDH1A1 (0.70) ALDH1A1MAPTPOLBHTTPKM
SCHEMBL3410406 0.73 ALDH1A1 (0.46) ALDH1A1MAPTHTTPKMKMT2A
SCHEMBL3032786 0.73 MEN1 (0.43) ALDH1A1MAPTPOLBHTTKMT2A
SCHEMBL3032884 0.72 TDP1 (0.46) ALDH1A1MAPTPOLBHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 US disclosed
EP-2166856-A1 CHEMICAL COMPOUNDS GlaxoSmithKline LLC (US) 2010-03-31 EP disclosed
WO-2008154271-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216746-A1 CHEMICAL COMPOUNDS SAMHD1, POLRMT, NUDT1 ALDH1A1 348/4885MAPT 791/4885POLB 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.